Evolent Health, Inc. - Class A Common Stock (EVH)

CUSIP: 30050B101

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+184,451
SEC-reported price per share
$3.49
Number of holders
20
Value change
+$511,972
Number of buys
8
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
112,392,185

Security key

30050B101

Report period

Q3 2026

Institutions

20

Top holders

10

Ownership snapshot

Top reported holders of EVH - Evolent Health, Inc. - Class A Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
CADIAN CAPITAL MANAGEMENT...
Disclosed value leader
CADIAN CAPITAL MANAGEMENT...
Comparable rows
8/15
Latest evidence
30 Jun 2026
13D/G 13F 3/4/5 Lead comparable stake: 9.3% 7 rows are not safely comparable across share classes. 13D/G row: CADIAN CAPITAL MANAGEMENT, LP Showing 1-6 of 15 holder rows.

Quick read

CADIAN CAPITAL MANAGEMENT, LP leads the comparable SEC ownership view at 9.3%.

8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens CADIAN CAPITAL MANAGEMENT, LP's linked filing trail.
Comparable ownership Top 5
CADIAN CAPITAL MANAGEMENT, LP 9.3%
VANGUARD GROUP INC 8%
BlackRock Portfolio Management LLC 5.5%
Adam Boehler 5.2%
RA CAPITAL MANAGEMENT, L.P. 3.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
CADIAN CAPITAL MANAGEMENT, LP
13D/G 13F
Company
9.3%
Reported 13D/G · 31 Mar 2025
$106,218,923
10,794,606 shares
$0 31 Mar 2025
VANGUARD GROUP INC
13D/G
The Vanguard Group
8%
Reported 13D/G · 31 Dec 2025
$35,656,260
8,914,065 shares
$0 31 Dec 2025
BlackRock Portfolio Management LLC
13D/G
5.5%
Reported 13D/G · 30 Jun 2026
$33,752,264
6,227,355 shares
$0 30 Jun 2026
Adam Boehler
13D/G
Rubicon OP GP II LP
5.2%
Reported 13D/G · 13 Nov 2025
$49,204,401
5,816,123 shares
$0 13 Nov 2025
RA CAPITAL MANAGEMENT, L.P.
13D/G
3.1%
Reported 13D/G · 31 Dec 2024
$35,199,618
3,577,197 shares
$0 31 Dec 2024
MORGAN STANLEY
13F 13D/G
Company
2.7%
Reported 13D/G · 31 Aug 2026
$48,612,048
8,969,012 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
20
Shares
701,453
Rows available
20
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
197
Q3 2026 holders
20
Holder diff
-177
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .